<SEC-DOCUMENT>0001193125-21-003104.txt : 20210106
<SEC-HEADER>0001193125-21-003104.hdr.sgml : 20210106
<ACCEPTANCE-DATETIME>20210106160801
ACCESSION NUMBER:		0001193125-21-003104
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210106
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210106
DATE AS OF CHANGE:		20210106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zai Lab Ltd
		CENTRAL INDEX KEY:			0001704292
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38205
		FILM NUMBER:		21510542

	BUSINESS ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
		BUSINESS PHONE:		862161632588

	MAIL ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d70511d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:zlab="http://www.zailaboratory.com/20210106" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2021-01-06_to_2021-01-06" name="dei:AmendmentFlag" contextRef="duration_2021-01-06_to_2021-01-06">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2021-01-06_to_2021-01-06" name="dei:EntityCentralIndexKey" contextRef="duration_2021-01-06_to_2021-01-06">0001704292</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="zlab-20210106.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-01-06_to_2021-01-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001704292</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-06</xbrli:startDate> <xbrli:endDate>2021-01-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-01-06_to_2021-01-06">8-K</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt:datemonthdayyearen">January 6, 2021</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-01-06_to_2021-01-06">Zai Lab Limited</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:edgarprovcountryen">Cayman Islands</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-01-06_to_2021-01-06">001-38205</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-01-06_to_2021-01-06">98-1144595</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(state or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-01-06_to_2021-01-06">4560 Jinke Road</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-01-06_to_2021-01-06">Bldg. 1</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2021-01-06_to_2021-01-06">Fourth Floor</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressRegion" contextRef="duration_2021-01-06_to_2021-01-06">Pudong</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-01-06_to_2021-01-06">Shanghai</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:countrynameen">China</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-01-06_to_2021-01-06">201210</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: +<ix:nonNumeric name="dei:CountryRegion" contextRef="duration_2021-01-06_to_2021-01-06">86</ix:nonNumeric> <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-01-06_to_2021-01-06">21</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-01-06_to_2021-01-06">6163 2588</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-01-06_to_2021-01-06">American Depositary Shares, each representing one Ordinary Shares, par value $0.00006 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-01-06_to_2021-01-06">ZLAB</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">Ordinary shares, par value $0.00006 per share*</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">9688</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">The Stock Exchange of Hong Kong Limited</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">* Included in connection with the registration of the American Depositary Shares with the Securities and Exchange Commission. The ordinary shares are not registered or listed for trading in the United States but are listed for trading on The Stock Exchange of Hong Kong Limited.</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-01-06_to_2021-01-06" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Summary </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;6, 2021 (U.S. time), Zai Lab Limited (the &#8220;Company&#8221;) entered into a collaboration and license agreement (the &#8220;Collaboration Agreement&#8221;) with argenx BV (&#8220;Argenx&#8221;) pursuant to which Zai Auto Immune (Hong Kong) Limited (&#8220;Zai Auto Immune&#8221;), a wholly-owned subsidiary of the Company, received an exclusive license to develop and commercialize products containing Argenx&#8217;s proprietary antibody fragment, known as efgartigimod, in mainland China, Hong Kong, Macau and Taiwan. On the same date, as partial consideration for the exclusive license granted by Argenx to Zai Auto Immune under the Collaboration Agreement, the Company entered into a share issuance agreement (&#8220;Share Issuance Agreement&#8221;) with Argenx pursuant to which the Company has agreed to issue 568,182 ordinary shares, par value US$0.00006 per share (the &#8220;Subscription Shares&#8221;) to Argenx in full satisfaction of the $75&#160;million upfront payment under the Collaboration Agreement.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction for the issuance of the Subscription Shares to Argenx under the Share Issuance Agreement has been approved by the boards of directors of both companies and is expected to close in January 2021, subject to approval by the Listing Committee of the Hong Kong Stock Exchange of the listing of the shares to be issued by the Company to Argenx on the Hong Kong Stock Exchange, and satisfaction of other customary closing conditions (the &#8220;Closing&#8221;).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of the Collaboration and License Agreement are further summarized below.</p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Collaboration and License Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January 06, 2021 (U.S. time), Zai Auto Immune entered into the Collaboration Agreement with Argenx, pursuant to which Zai Auto Immune received an exclusive license under relevant patents and <span style="white-space:nowrap">know-how</span> to develop and commercialize Argenx&#8217;s proprietary antibody fragment, efgartigimod (the &#8220;Licensed Compound&#8221;) and biopharmaceutical products containing the Licensed Compound (the &#8220;Licensed Products&#8221;) in mainland China, Hong Kong, Macau and Taiwan (the &#8220;Territory&#8221;). Under the Collaboration Agreement, Zai Auto Immune may participate in Argenx&#8217;s global phase 3 trials for Licensed Products by enrolling patients in the Territory.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Collaboration Agreement, Zai Auto Immune will be responsible for the development of the Licensed Compound and Licensed Products in the Territory in accordance with a development plan to support the regulatory approval of the Licensed Product in the Territory.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For each Licensed Product that is approved in the Territory, Zai Auto Immune will have the right to commercialize such Licensed Product in the Territory, during which Argenx is eligible to receive tiered royalties <span style="white-space:nowrap">(mid-teen</span> to <span style="white-space:nowrap">low-twenties</span> on a percentage basis and subject to customary reductions) based on annual net sales of all Licensed Products in the Territory. Zai Auto Immune&#8217;s royalty obligations will continue on a <span style="white-space:nowrap"><span style="white-space:nowrap">jurisdiction-by-jurisdiction</span></span> and Licensed <span style="white-space:nowrap"><span style="white-space:nowrap">Product-by-Licensed</span></span> Product basis until the last to occur of (i)&#160;expiration of the last valid claim of a licensed patent that covers such Licensed Product in such jurisdiction, (ii)&#160;expiration of regulatory exclusivity in such jurisdiction for such Licensed Product and (iii)&#160;twelve years from the first commercial sale of such Licensed Product in such jurisdiction.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In partial consideration of the license granted to Zai Auto Immune, a $75&#160;million upfront payment will be made to Argenx through the issuance by the Company of 568,182 Subscription Shares calculated at a price of $132.00 per share. In addition, Zai Auto Immune will make a guaranteed <span style="white-space:nowrap">non-creditable,</span> <span style="white-space:nowrap">non-refundable</span> development cost-sharing payment of $75&#160;million to Argenx, and a cash payment of $25&#160;million upon the first regulatory approval of a Licensed Product by the U.S. Food and Drug Administration for Myasthenia Gravis.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Collaboration Agreement contains customary representations, warranties and covenants by the parties. Unless terminated earlier pursuant to its terms, the agreement will continue in effect on a <span style="white-space:nowrap"><span style="white-space:nowrap">jurisdiction-by-jurisdiction</span></span> and Licensed <span style="white-space:nowrap"><span style="white-space:nowrap">Product-by-Licensed</span></span> Product basis until expiration of the royalty term for such Licensed Product in such jurisdiction. The Collaboration Agreement may be terminated by either party upon the other party&#8217;s uncured material breach, bankruptcy, insolvency or similar event. In addition, Zai Auto Immune may terminate the</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Collaboration Agreement for any or no reason upon 180 days&#8217; prior written notice of Argenx. If Zai Auto Immune or any of its affiliates or sublicensees challenges a patent licensed by Argenx under the Collaboration Agreement as invalid, unenforceable or otherwise not patentable, Argenx will have the right to immediately terminate the Collaboration Agreement, subject to certain exceptions. In addition, if a force majeure event is specific to Zai Auto Immune and persists for a specified period of time, Argenx will have the right to terminate the Collaboration Agreement upon notice to Zai Auto Immune.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">* * *</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The foregoing description of the terms of the Collaboration Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreement, which the Company intends to file as an exhibit to a subsequent periodic report or on an amendment to this Current Report on Form <span style="white-space:nowrap">8-K.</span>&#160;</span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">* * *</p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">The representations and warranties and other statements in the agreements (1)&#160;speak only as to the date on which they were made, and may be modified or qualified by confidential schedules or other disclosures, agreements or understandings among the parties, which the parties believe are not required by the securities laws to be publicly disclosed, and (2)&#160;may be subject to a different materiality standard than the standard that is applicable to disclosures to investors. Moreover, it was advised that information concerning the subject matter of the representations and warranties and other statements made in the various agreements would likely change after the execution date of such agreements, and subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. Accordingly, investors should not rely upon representations and warranties and other statements in the various agreements as factual characterizations of the actual state of affairs of the Company. Investors should instead look to disclosures contained in the Company&#8217;s reports under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). </span></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth under Item 1.01 with respect to the issuance of the Subscription Shares, consisting of 568,182 ordinary shares of the Company, pursuant to the Share Subscription Agreement is incorporated by reference into this Item 3.02. Based upon the outstanding ordinary shares of the Company as of January&#160;5, 2021, the Subscription Shares upon issuance will represent less than 1% of the outstanding ordinary shares of the Company.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuance of shares pursuant to the Share Issuance Agreement will be made in reliance upon Regulation S under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) to Argenx, a <span style="white-space:nowrap">non-U.S.</span> person and will be restricted securities under the Securities Act.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;6, 2021 (U.S. time), the Company issued a press release announcing the above-described transactions. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing or this Current Report.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d70511dex991.htm">Press Release, dated January&#160;6, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page of this Current Report on Form <span style="white-space:nowrap">8-K</span> is formatted in Inline XBRL</td></tr></table></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">ZAI LAB LIMITED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Billy Cho</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Billy Cho</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Financial Officer</td></tr></table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: January&#160;6, 2021</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><span style="text-decoration:underline">Exhibit Index </span></p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibit 99.1&#8212;Press Release</p></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d70511dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g70511g0106174635461.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g70511g0106174635742.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more
rapidly advance new potential indications into clinical development each year </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Zai Lab granted exclusive rights to develop and commercialize efgartigimod in Greater China
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">argenx to receive $75&nbsp;million in upfront Zai Lab equity and $100&nbsp;million in near-term milestone and
other payments </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Regulated Information/Inside Information </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Breda, the Netherlands, Shanghai and San Francisco &#150; Jan. 6, 2021 &#150; </B>argenx SE (Euronext&nbsp;&amp; NASDAQ: ARGX), a global immunology company
committed to improving the lives of people suffering from severe autoimmune diseases and cancer, and Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced an exclusive license agreement
for the development and commercialization of efgartigimod in Greater China, including mainland&nbsp;China,&nbsp;Hong Kong,&nbsp;Taiwan&nbsp;and&nbsp;Macau. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Through this collaboration with Zai Lab, we are expanding our global footprint in one of the world&#146;s fastest growing markets and reaching more
people living with severe autoimmune diseases. By leveraging Zai Lab&#146;s strong local expertise within Greater China and proven development capabilities, we aim to provide broad access to efgartigimod in these important markets as well as
accelerate the number of autoimmune indications in clinical development,&#148; said Tim Van Hauwermeiren, Chief Executive Officer of argenx. &#147;We believe that Zai Lab is the ideal partner for us ahead of our first potential approval of
efgartigimod in generalized myasthenia gravis (gMG) in the U.S. and we are aligned in our mutual passion to bring potential innovative immunology therapies to patients in need.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;argenx is building a leading immunology company and we are excited to collaborate with them during this important time. Efgartigimod is being evaluated
in a broad range of autoimmune diseases and we look forward to bringing this potentially <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> product to patients in Greater China,&#148; said
Dr.&nbsp;Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab. &#147;This collaboration also significantly expands and strengthens our pipeline in severe autoimmune diseases, where there is an urgent and serious need for new
therapeutic options.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;There are an estimated 200,000 people living with MG in China,&#148; said Dr.&nbsp;Harald Reinhart, Chief Medical
Officer for Autoimmune and Infectious Diseases, Zai Lab. &#147;The unmet medical need is significant for these patients, with very limited treatment options. We believe efgartigimod has a promising profile that, if approved, can potentially change
the treatment paradigm not only of gMG but of other autoimmune diseases.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, Zai Lab obtains the exclusive right to
develop and commercialize efgartigimod in Greater China.&nbsp;Zai Lab&nbsp;will recruit Chinese patients to argenx&#146;s global registrational trials for the development of efgartigimod. Additionally, this agreement is expected to allow argenx to
accelerate efgartigimod development by initiating multiple Phase 2 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> trials in new autoimmune indications. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">argenx will receive $175&nbsp;million in collaboration payments, comprised of a $75&nbsp;million upfront
payment in the form of 568,182 newly issued Zai Lab shares calculated at a price of $132.00 per share, $75&nbsp;million as a guaranteed <FONT STYLE="white-space:nowrap">non-creditable,</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT>
development cost-sharing payment, and an additional $25&nbsp;million milestone payment upon approval of efgartigimod in the U.S. argenx is also eligible to receive tiered royalties <FONT STYLE="white-space:nowrap">(mid-teen</FONT> to <FONT
STYLE="white-space:nowrap">low-twenties</FONT> on a percentage basis) based on annual net sales of efgartigimod in Greater China. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Efgartigimod
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Efgartigimod is an investigational antibody fragment designed to reduce disease-causing immunoglobulin G (IgG) antibodies and block the IgG recycling
process. Efgartigimod binds to the neonatal Fc receptor (FcRn), which is widely expressed throughout the body and plays a central role in rescuing IgG antibodies from degradation. Blocking FcRn reduces IgG antibody levels, representing a logical
potential therapeutic approach for several autoimmune diseases known to be driven by disease-causing IgG antibodies, including: myasthenia gravis (MG), a chronic disease that causes muscle weakness; pemphigus vulgaris (PV), a chronic disease
characterized by severe blistering of the skin; immune thrombocytopenia (ITP), a chronic bruising and bleeding disease; and chronic inflammatory demyelinating polyneuropathy (CIDP), a neurological disease leading to impaired motor function. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About argenx </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">argenx is a global immunology company
committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a
world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier
stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, and Japan. For more information, visit www.argenx.com and follow us on LinkedIn at <U>https://www.linkedin.com/company/argenx/.</U>
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Zai Lab </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zai Lab (NASDAQ:ZLAB; HKEX: 9688) is
an innovative commercial-stage biopharmaceutical company focused on bringing transformative medicines for cancer and infectious and autoimmune diseases to patients in China and around the world. We aim to address significant unmet medical needs in
large, fast-growing segments of the pharmaceutical market. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and drug
candidates. We have also built an <FONT STYLE="white-space:nowrap">in-house</FONT> team with strong drug discovery and translational research capabilities and are establishing a pipeline of proprietary drug candidates with global rights. Our vision
is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For additional information about the company, please visit www.zailaboratory.com or follow us on Linkedin<BR> at
https://www.linkedin.com/company/zai-lab/mycompany/ and Twitter at <U>www.twitter.com/ZaiLab_Global</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>argenx Contacts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kelsey Kirk </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>KKirk@argenx.com </U></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beth DelGiacco </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>bdelgiacco@argenx.com </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joke Comijn (EU) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>jcomijn@argenx.com </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Zai Lab Contacts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Billy Cho, CFO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+86 137 6151 2501 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">billy.cho@zailaboratory.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media</B>: Ryo Imai / Robert Flamm, Ph.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Burns McClellan, on
behalf of Zai Lab </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-213-0006</FONT></FONT> ext. 315 / 364 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">rimai@burnsmc.com / rflamm@burnsmc.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors</B>: Mike
Zanoni </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Endurance Advisors, on behalf of Zai Lab </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">610-442-8570</FONT></FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">mzanoni@enduranceadvisors.com </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>argenx Forward-looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The contents of
this announcement include statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms believes, estimates, anticipates,
expects, intends, may, will, or should, and include statements argenx makes concerning the therapeutic potential of its product candidates; the intended results of its strategy; the expected benefits of the collaboration with Zai Lab; its and its
collaboration partners&#146; clinical development and regulatory plans, including the timing, design and outcome of ongoing and planned clinical trials and the timing and outcome of regulatory filings and approvals; and the timing and progress of
commercialization activities. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. argenx&#146;s actual results may
differ materially from those predicted by the forward-looking statements as a result of various important factors, including the effects of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the inherent uncertainties associated with
preclinical and clinical trial and product development activities and regulatory approval requirements; argenx&#146;s reliance on collaborations with third parties; estimating the commercial potential of argenx&#146;s product candidates;
argenx&#146;s ability to obtain and maintain protection of intellectual property for its technologies and drugs; argenx&#146;s limited operating history; and argenx&#146;s ability to obtain additional funding for operations and to complete the
development and commercialization of its product candidates. A further list and description of these risks, uncertainties and other risks can be found in argenx&#146;s U.S. Securities and Exchange Commission (SEC) filings and reports, including in
argenx&#146;s most recent annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> filed with the SEC as well as subsequent filings and reports filed by argenx with the SEC. Given these uncertainties, the reader is advised not to place any
undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. argenx undertakes no obligation to publicly update or revise the information in this press release,
including any forward-looking statements, except as may be required by law. </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Zai Lab Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains statements about future expectations, plans and prospects for Zai Lab, including, without limitation, statements regarding the
prospects of and plans for commercializing efgartigimod in Greater China. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements
of historical fact nor are they guarantees or assurances of future performance. Forward-looking statements are based on Zai Lab&#146;s expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks
and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors,
including but not limited to (1)&nbsp;Zai Lab&#146;s ability to obtain additional future funding, (2)&nbsp;Zai Lab&#146;s results of clinical and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> development of its drug candidates, (3)&nbsp;the
content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of Zai Lab&#146;s drug candidates, (4)&nbsp;Zai Lab&#146;s ability to generate revenue from its drug candidates, (5)&nbsp;the effects of the
novel coronavirus <FONT STYLE="white-space:nowrap">(COVID-19)</FONT> pandemic on general economic, regulatory and political conditions and (6)&nbsp;other factors discussed in Zai Lab&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">20-F</FONT> for the fiscal year ended December&nbsp;31, 2019, filed on April&nbsp;29, 2020, and its other filings with the Securities and Exchange Commission. Zai Lab anticipates that subsequent events and
developments will cause Zai Lab&#146;s expectations and assumptions to change and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may
be required by law. These forward-looking statements should not be relied upon as representing Zai Lab&#146;s views as of any date subsequent to the date of this press release. </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>zlab-20210106.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 66.8 -->
<!-- Creation date: 1/6/2021 4:15:38 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:zlab="http://www.zailaboratory.com/20210106"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.zailaboratory.com/20210106"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20210106_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zlab-20210106_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>zlab-20210106_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 66.8 -->
<!-- Creation date: 1/6/2021 4:15:38 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressRegion" xlink:type="locator" xlink:label="dei_EntityAddressRegion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressRegion" xlink:to="dei_EntityAddressRegion_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Region</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Country Region</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Country Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>zlab-20210106_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 66.8 -->
<!-- Creation date: 1/6/2021 4:15:38 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="zlab-20210106.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="26.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressRegion" xlink:type="locator" xlink:label="dei_EntityAddressRegion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressRegion" order="26.121" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.061" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.161" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CountryRegion" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="33.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="33.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g70511g0106174635461.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g70511g0106174635461.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S -$# 2(  A$! Q$!_\0
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MTHUTHVZE5\BE*NYJ2Y&[^AF:?,USXFM+AA\TM\DA^ID!_K7=_&K_ )&/3?\
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M/A&]N9/%5H3>2&!IE0AIB58['/?']Y>,?RKV6E&,9:V*Q%;$X>2A[1LY;0/
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;<C Z=>:**!*4ELS1HHHIDA1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g70511g0106174635742.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g70511g0106174635742.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  [ *L# 2(  A$! Q$!_\0
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@5Z#110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d70511d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zlab-20210106.xsd" xlink:type="simple"/>
    <context id="duration_2021-01-06_to_2021-01-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001704292</identifier>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-01-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="duration_2021-01-06_to_2021-01-06"
      id="Hidden_dei_AmendmentFlag_duration_2021-01-06_to_2021-01-06">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-01-06_to_2021-01-06"
      id="Hidden_dei_EntityCentralIndexKey_duration_2021-01-06_to_2021-01-06">0001704292</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-01-06_to_2021-01-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-01-06_to_2021-01-06">2021-01-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-01-06_to_2021-01-06">Zai Lab Limited</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-01-06_to_2021-01-06">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-01-06_to_2021-01-06">001-38205</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-01-06_to_2021-01-06">98-1144595</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-01-06_to_2021-01-06">4560 Jinke Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-01-06_to_2021-01-06">Bldg. 1</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2021-01-06_to_2021-01-06">Fourth Floor</dei:EntityAddressAddressLine3>
    <dei:EntityAddressRegion contextRef="duration_2021-01-06_to_2021-01-06">Pudong</dei:EntityAddressRegion>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-01-06_to_2021-01-06">Shanghai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="duration_2021-01-06_to_2021-01-06">CN</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-01-06_to_2021-01-06">201210</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion contextRef="duration_2021-01-06_to_2021-01-06">86</dei:CountryRegion>
    <dei:CityAreaCode contextRef="duration_2021-01-06_to_2021-01-06">21</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-01-06_to_2021-01-06">6163 2588</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-01-06_to_2021-01-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-01-06_to_2021-01-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-01-06_to_2021-01-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-01-06_to_2021-01-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-01-06_to_2021-01-06">American Depositary Shares, each representing one Ordinary Shares, par value $0.00006 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-01-06_to_2021-01-06">ZLAB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-01-06_to_2021-01-06">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-01-06_to_2021-01-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140336366529688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  06,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zai Lab Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1144595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4560 Jinke Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bldg. 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Fourth Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Shanghai<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressRegion', window );">Entity Address, Region</a></td>
<td class="text">Pudong<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">201210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6163 2588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one Ordinary Shares, par value $0.00006 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZLAB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001704292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the region.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M ($F4MI\0_[M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @  ($F4IE<G",0!@  G"<  !,
M ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "   @292Q&V$
M>Z$$  #/$@  &               @($,"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @  ($F4H.II0/4 0  ,@8   T
M ( !XPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "   @292EXJ[',     3
M @  "P              @ 'B#@  7W)E;',O+G)E;'-02P$"% ,4    "
M@292'#AEZC\!   \ @  #P              @ '+#P  >&PO=V]R:V)O;VLN
M>&UL4$L! A0#%     @  ($F4B0>FZ*M    ^ $  !H              ( !
M-Q$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  ($F
M4F60>9(9 0  SP,  !,              ( !'!(  %M#;VYT96YT7U1Y<&5S
;72YX;6Q02P4&      D "0 ^ @  9A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>98</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d70511d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d70511d8k.htm">d70511d8k.htm</File>
    <File>d70511dex991.htm</File>
    <File>zlab-20210106.xsd</File>
    <File>zlab-20210106_lab.xml</File>
    <File>zlab-20210106_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d70511d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d70511d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "zlab-20210106_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zlab-20210106_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "zlab-20210106.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 98,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "zlab",
   "nsuri": "http://www.zailaboratory.com/20210106",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d70511d8k.htm",
      "contextRef": "duration_2021-01-06_to_2021-01-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d70511d8k.htm",
      "contextRef": "duration_2021-01-06_to_2021-01-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the region.",
        "label": "Entity Address, Region",
        "terseLabel": "Entity Address, Region"
       }
      }
     },
     "localname": "EntityAddressRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.zailaboratory.com//20210106/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-21-003104-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-003104-xbrl.zip
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M+\+0C+E/"=)VC3Z/>1"DG]U2;JN^"D,^-J*;_G$WA[ RA!897KO]O4-=M^W
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MWR/NY$[WYD2LGV0X0?4E=:14AM-=\?'@YOC@OW?$P?79SR\Z0N:!4X=A%IG
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MC'>6)"Z9&++/JE+\PKU4/"(Y9F0&BL]PBH\YDG'04W[/*?8;F:7S[Y!\F.F
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M*-UM9 Q#3905BW(.J["[%/L[]1AWTQ3A;?W4NXY>$#75WH3D@1M4EN["\ D
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MZDI:3?K[W=/<WJC)TB_:J07V5&GDA^L:)C  6FO)1MU@.).B#:N<IB?.N"/
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M<+2*N()T71[_@C?YWY+[7U!+ P04    "   @292@.42O2$#  #8"@  $0
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MDXZ== C4PWHK4'C-&4\V@1$&-SQ:)L"4?>^R^)8IHC9]-N4B2;OCH32S[;F
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M4$L! A0#%     @  ($F4BW?E.O8&   4)$   T              ( !
M &0W,#4Q,60X:RYH=&U02P$"% ,4    "   @292WD0(<\X5  !23@  $
M            @ $#&0  9#<P-3$Q9&5X.3DQ+FAT;5!+ 0(4 Q0    (  "!
M)E* Y1*](0,  -@*   1              "  ?\N  !Z;&%B+3(P,C$P,3 V
M+GAS9%!+ 0(4 Q0    (  "!)E)W#XASU@8  %Y/   5              "
M 4\R  !Z;&%B+3(P,C$P,3 V7VQA8BYX;6Q02P$"% ,4    "   @292N4R1
MIMP$  #*,0  %0              @ %8.0  >FQA8BTR,#(Q,#$P-E]P<F4N
9>&UL4$L%!@     %  4 /@$  &<^      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
